Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation

被引：3
|
作者：
Asawapanumas, Thiti [1 ,2 ,3 ]
Chanswangphuwana, Chantiya [1 ,2 ,3 ]
Watanaboonyongcharoen, Phandee [4 ,5 ]
Rojnuckarin, Ponlapat [1 ,2 ,3 ]
Bunworasate, Udomsak [1 ,2 ,3 ]
机构：
[1] Chulalongkorn Univ, Fac Med, Div Hematol, Dept Med, Rama IV Rd, Bangkok 10330, Thailand
[2] King Chulalongkorn Mem Hosp, Rama IV Rd, Bangkok 10330, Thailand
[3] Chulalongkorn Univ, Res Unit Translat Hematol, Bangkok, Thailand
[4] Chulalongkorn Univ, Fac Med, Dept Lab Med, Bangkok, Thailand
[5] King Chulalongkorn Mem Hosp, Transfus Med Unit, Bangkok, Thailand
来源：
LEUKEMIA RESEARCH REPORTS | 2022年 / 17卷
关键词：
Daratumumab; Pure red cell aplasia; Major ABO-mismatched;
D O I：
10.1016/j.lrr.2022.100314
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [41] MAJOR AND BIDIRECTIONAL ABO INCOMPATIBILITY RELATED PURE RED CELL APLASIA DOES NOT COMPROMISE THE OUTCOME POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Sakellari, I.
    Bousiou, Z.
    Mallouri, D.
    Abela, E.
    Kaloyannidis, P.
    Apostolou, C.
    Yannaki, E.
    Batsis, I.
    Smias, C.
    Kynigopoulou, P.
    Fitili, C.
    Sotiropoulos, D.
    Ganidou, M.
    Bamihas, G.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S32 - S32
  • [42] Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation
    Fang, Baijun
    Song, Yongping
    Li, Ning
    Li, Jing
    Han, Qin
    Zhao, Robert Chunhua
    ANNALS OF HEMATOLOGY, 2009, 88 (03) : 261 - 266
  • [43] Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation
    Baijun Fang
    Yongping Song
    Ning Li
    Jing Li
    Qin Han
    Robert Chunhua Zhao
    Annals of Hematology, 2009, 88 : 261 - 266
  • [44] Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant
    Sackett, Katie
    Cohn, Claudia S.
    Fahey-Ahrndt, Kayla
    Smith, Angela R.
    Johnson, Andrew D.
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (01) : 108 - 112
  • [45] Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia
    Pepeler, Mehmet Sezgin
    Dagdas, Simten
    Isleyen, Emel
    Katayifci, Gaye
    Kilicarslan, Aydan
    Ozhamam, Esra
    Adakul, Muhammed Talha
    Ozturk, Fahir
    Ceran, Funda
    Ozet, Gulsum
    TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (04) : 288 - 290
  • [46] Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu, Kanger
    Li, Jun-ping
    Zhang, Tao
    BLOOD, 2006, 108 (11) : 401B - 401B
  • [47] Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation
    Khan, Fatima
    Linden, Michael A.
    Zantek, Nicole D.
    Vercellotti, Gregory M.
    BLOOD, 2013, 122 (21)
  • [48] Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning
    H Veelken
    R Wäsch
    D Behringer
    H Bertz
    J Finke
    Bone Marrow Transplantation, 2000, 26 : 911 - 915
  • [49] Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning
    Veelken, H
    Wäsch, R
    Behringer, D
    Bertz, H
    Finke, J
    BONE MARROW TRANSPLANTATION, 2000, 26 (08) : 911 - 915
  • [50] Allogeneic stem cell transplantation for acquired pure red cell aplasia
    Halkes, Constantijn
    de Wreede, Liesbeth C.
    Knol, Cora
    Simand, Celestine
    Aljurf, Mahmoud
    Tbakhi, Abdelghani
    Vazquez, Lourdes
    Bloor, Adrian
    Wagner-Drouet, Eva
    Vural, Filiz
    Bodova, Ivana
    Isaksson, Cecilia
    Diaz, Miguel Angel
    Gruhn, Bernd
    Snowden, John
    Arat, Mutlu
    Bazarbachi, Ali
    Spilleboudt, Chloe
    Kulagin, Alexander
    Marsh, Judith C. W.
    Passweg, Jakob
    Risitano, Antonio M.
    Peffault de Latour, Regis
    Dufour, Carlo
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (11) : E294 - E296
12345